| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0096 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |